Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

S

Sutter Health

Status

Completed

Conditions

HIV Infections
Toxoplasmosis, Cerebral

Treatments

Drug: Pyrimethamine
Drug: Clindamycin

Study type

Interventional

Funder types

Other

Identifiers

NCT00002064
021A

Details and patient eligibility

About

To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria

Co-existing Condition:

Patients with the following conditions are excluded:

  • Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy.

Patients with other opportunistic infections or brain diseases are excluded.

Patients with AIDS and cerebral toxoplasmosis.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems